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The accumulation of amyloid peptide(1–42) (A(1–42)) in
extracellular plaques is one of the pathological hallmarks of
Alzheimer disease (AD). Several studies have suggested that cel-
lular reuptake of A(1–42) may be a crucial step in its cytotox-
icity, but the uptake mechanism is not yet understood. Amay
be present in an aggregated form prior to cellular uptake. Alter-
natively, monomeric peptide may enter the endocytic pathway
and conditions in the endocytic compartments may induce the
aggregation process. Our study aims to answer the question
whether aggregate formation is a prerequisite or a consequence
of A endocytosis. We visualized aggregate formation of fluo-
rescently labeled A(1–42) and tracked its internalization by
human neuroblastoma cells and neurons. -Sheet-rich A(1–
42) aggregates entered the cells at lownanomolar concentration
of A(1–42). In contrast, monomer uptake faced a concentra-
tion threshold and occurred only at concentrations and time
scales that allowedA(1–42) aggregates to form. By uncoupling
membrane binding from internalization, we found that A(1–
42) monomers bound rapidly to the plasma membrane and
formed aggregates there. These structures were subsequently
taken up and accumulated in endocytic vesicles. This process
correlated with metabolic inhibition. Our data therefore imply
that the formation of -sheet-rich aggregates is a prerequisite
for A(1–42) uptake and cytotoxicity.
One of the pathological hallmarks of Alzheimer disease
(AD)2 is the presence of extracellular plaques composedmainly
of 42-amino acid amyloid  peptide (A(1–42)) (1). The small
hydrophobic A(1–42) peptide, which is generated by proteo-
lytic cleavage of the amyloid precursor protein, is released as a
monomer from the plasma membrane into extracellular space,
and tends to aggregate spontaneously into oligomeric, protofi-
brillar, and fibrillar assemblies (2–4). Oligomeric species of
A(1–42) are tightly linked to AD pathogenesis and are pre-
sumed to be the cause of neuronal damage (5). Several studies
have suggested that the reuptake of extracellularA(1–42) into
neurons may lead to the formation of intracellular aggregates,
resulting in neuronal damage and neurotoxicity (6–8). Endo-
cytosis of misfolded proteins has also been observed in cell
models of the tau protein, -synuclein and huntingtin (9, 10),
and recent evidence suggests that itmay be the initial step in the
replication of the misfolded protein structures by prion mech-
anisms (10–14). Several possible endocytic pathways, such as
macropinocytosis and receptor-mediated endocytosis, have
been discussed for A and other misfolded protein aggregates
(15–19). However, our understanding of the connection
between aggregation and cytotoxicity is still limited. It has not
been conclusively determined how and when the A(1–42) pep-
tidebecomes toxic,whetherA aggregatesprior to internalization
or during the internalization process and, if so, in which intracel-
lular compartments the aggregates form. Elucidating the connec-
tionbetweenaggregationand internalizationofA(1–42)peptide
may be thus vital in understanding its toxicity.
Here, we examine the relationship between the aggregation
state of extracellular A(1–42) and the efficiency of its inter-
nalization. We aimed to determine whether the formation of
aggregates and particularly-sheet-rich structures, as reported
by thioflavin dyes (20) and conformation-specific antibodies is
a prerequisite for its neuronal uptake.
We found that cultured human neuroblastoma cells (SH-EP
cells) can efficiently internalize -sheet-rich aggregates of A(1–
42) at nanomolar concentrations, and that cellular uptake was
associated with metabolic inhibition. In contrast, monomeric
A(1–42) only entered cells inefficiently and at high nanomolar
concentrations. Internalization occurred after aggregation on the
plasmamembrane, which suggests that themembrane is an envi-
ronment that facilitates aggregation of A(1–42) monomers.
Results
Preparation and Characterization of Fluorescently Labeled
A(1–42)—To investigate the relationship between the aggre-
gation state of A(1–42), its internalization and cytotoxicity,
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we examined whether the presence of the secondary structure
determines the behavior of A(1–42) toward the cells and
membranes. Aggregated A, which may contain oligomers,
protofibrils, and fibrils, was classified in two populations: a state
without -sheet structure and a state in which -sheets have
been formed. Concentrations of aggregated A(1–42) peptide
are expressed in terms of their amount of A monomers as
“equivalent monomer concentration.”
To track the peptide and to observe aggregation of mono-
meric A(1–42) in cultured cells, we generated A(1–42)
peptides that were fluorescently labeled at the N terminus
with Atto565-maleimide (A(1–42)565), Atto488-maleim-
ide (A(1–42)488), or Atto633-maleimide (A(1–42)633) as
described below. LabeledA(1–42)was separated by size exclu-
sion chromatography (SEC, Fig. 1A).A eluted in twopopulations
at 0.86 (protofibrils, PF) and 1.39ml (monomer, M).
Weused unlabeledmonomers and aggregation-incompetent
sc-A(1–42)565 as controls on SEC, both of which eluted sim-
ilar to the A(1–42)565 monomer fraction (M, Fig. 1A). Those
monomers could not be detected by atomic force microscopy
(AFM, Fig. 1B). In contrast, AFM identified the PF fraction of
A(1–42)565 to be protofibrils with an average height of 4 nm
(Fig. 1B). When incubated with ThT, the protofibrils (35 M
monomerequivalent)boundthedye immediatelyandThTfluo-
rescence changed little over the course of 1 h, whereas ThT
fluorescence of the monomeric A (35 M) displayed sigmoid
kinetics typical of nucleated polymerization (Fig. 1C).
To further examine whether the fluorescence label influ-
enced A(1–42) monomer aggregation, we compared fibril
formation kinetics and fibril morphologies of labeled and unla-
beled A(1–42). Unlabeled monomeric A(1–42) was mixed
with 10% A(1–42)565 (total A(1–42) concentration of 15
M) and incubated in PBS at 25 °C. Aggregation kinetics were
monitored by binding of ThT in vitro (Fig. 1D) (21). The addi-
tion of 10% A(1–42)565 monomer slowed the formation of
fibers only slightly, without changing fibril structure, as
observed by AFM (Fig. 1,D and E).We imaged fibrils formed in
the presence of A(1–42)633 by fluorescence microscopy using
ThT fluorescence and A(1–42)633 fluorescence (Fig. 1F). A
high degree of correlation between the signals in both channels
demonstrated that all fibrils did indeed incorporate labeled
A(1–42) (Fig. 1G).
We used labeledmonomers (M) and protofibrils (PF, Fig. 1B)
to compare their respective cellular uptake. Mature fibrils (Fig.
1E) were used to compare their uptake to that of protofibrils
and monomers. For kinetic analysis of cellular uptake mixtures
of 90% unlabeled A(1–42) and 10% A(1–42)565 were used.
Efficient Uptake of A(1–42) Protofibrils—We treated cul-
tured human neuroblastoma (SH-EP) cells with A(1–42)565
monomers or protofibrils to determine whether both A spe-
cies are internalized differently. Cells were imaged by confocal
microscopy after incubation with A(1–42)565 at 37 °C for 24 h
(Fig. 2, A–E). A soluble membrane-impermeable fluorescent
dye, calcein (20 M), was added to the extracellular medium to
mark the uptake of extracellular medium during vesicular traf-
ficking from the plasma membrane into the cells in endocytic
vesicles (Fig. 3A). Intracellular A(1–42)565 could be detected
after treatmentwithprotofibrils (150nM,Fig. 2A) orwithmono-
mers at a higher concentration (500 nM, Fig. 2B). Treatment
with low concentrations of monomeric A(1–42)565 (150 nM,
Fig. 2C) or with an aggregation-incompetent scrambled pep-
tide, sc-A(1–42)565 (500 nM, Fig. 2D), did not lead to detecta-
ble A(1–42)565 inclusions, as was the case for untreated cells
(Fig. 2E, n.c.). Quantitative analysis of A(1–42)565 fluores-
cence in the endocytic vesicles and in the cytosol revealed that a
low level cytosolic A(1–42)565 signal could be detected after
treatmentwith protofibrils (150 nM) or high concentration (500
nM)monomeric A(1–42) but not at lowmonomer concentra-
tions (150 nM). The A(1–42)565 signal in the surrounding
cytosol was about 30-fold lower than in the vesicles (Fig. 2F).
The lack of uptake of sc-A(1–42)565 demonstrated that inter-
nalization was specific for the A(1–42) sequence and was not
a result of the fluorescent label (Fig. 2D).
We then verified that internalization of A(1–42)565 into
endocytic vesicles was also observed in primary hippocampal
neurons (Fig. 3, A–C). After incubating neurons with aggre-
gated A(1–42)565 (150 nM), monomeric A(1–42)565 (150 or
500 nM), and calcein (20 M) at 37 °C for 1 day, the uptake of
A(1–42)565 and the colocalization of internalized A(1–
42)565 and calcein were observed for aggregatedA(1–42) (Fig.
3A) and for monomeric A(1–42) at 500 nM (Fig. 3B), but not
for monomeric A(1–42) at 150 nM (Fig. 3C), supporting our
results from the neuroblastoma cell model. On the images,
internalized A(1–42)565 shown in neurons (Fig. 3, A and B)
and SH-EP cells (Fig. 2, A and B) seem different in quantity
and distribution, which may be the result of the isolation of
glia-free hippocampal neurons, or may reflect a general
higher endocytic activity of neurons under the same experi-
mental conditions.
To test whether exogenous fluorescence represented A
species, we co-stained cells with the anti--amyloid anti-
body 6E10, which confirmed that Atto565 fluorescence
indeed indicated the presence of A (Fig. 3, D and E). Con-
versely, 6E10 staining detected only endogenous amyloid
precursor protein in the absence of A(1–42)565 (Fig. 3F).
These results suggest that protofibrillar A(1–42) is taken
up at lower concentrations than the monomers, and that an
effective uptake of monomer may require A to form an
ordered aggregate structure prior to cellular uptake.
Uptake of Monomer Requires a MinimumA Concentration—
To quantitatively analyze the dependence of monomer uptake
on the concentration of A(1–42), we titrated the cells
either with A(1–42) monomer or protofibrils at 15–1500
nM (equivalent monomer concentration), and quantified
intracellular A(1–42) as a function of A(1–42) concen-
tration by the fluorescence of labeled A(1–42) using HCS
microscopy (Fig. 4A).
We tracked the amount of internalized A as a function of
time and found maximal intracellular A(1–42) signal after
24 h (Fig. 4B). The treatment with monomeric A(1–42)
(200 nM) did not result in cell death within 49 h (data not
shown). We thus used 24 h incubation for subsequent HCS
microscopy experiments. For monomeric A(1–42), the
total amount of intracellular A(1–42) as well as the number
of aggregates and their area was proportional to A(1–42)
monomer concentrations in the medium. No intracellular
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FIGURE 1. Purification of fluorescently labeled A(1–42) species. A, separation of A(1–42) by SEC. Labeled peptides eluted in a protofibril (PF) and a
monomer (M) fraction. Peptides and labels were detected by absorption at 280 nM and 565 nm, respectively. The elution locations of monomers, Atto565-
labeledA(1–42) (A42/a565), unlabeledmonomeric A(1–42) (A42mono.), andAtto565-labeled scrambled-A(1–42) (sc-A42/a565), have very similar SEC
elution profiles. B, no aggregates were detected by AFM in the A(1–42)565 monomer fraction collected from SEC (1.39 ml). A(1–42)565 protofibrils with an
average height of about 4 nm could be detected in the protofibril fraction of SEC. C, unlabeled monomeric A(1–42) (35 M), A(1–42) protofibrils (35 M
monomer equivalent), and an elution fraction at 0.5 ml on SEC (20 l) were incubated in PBS in presence of ThT (20 M). ThT fluorescence of monomers
displayed typical sigmoid kinetics. Protofibrils bound ThT immediately and stayed constant in fluorescence. D, monomeric A(1–42) was mixed with 10%
A(1–42)565 monomers and incubated in PBS. Aggregation was monitored by ThT fluorescence. The curves were normalized to the maximum intensity of
fluorescence of plateaus. All results are represented as mean values of 3 replicate wells. E, unlabeled monomeric A(1–42) or A(1–42) mixed with 10%
A(1–42)565was incubated in PBS for 2 days. Similar fibril structureswere detected in both samples. F, fluorescencemicroscopy of A(1–42) aggregated in the
absence or presence of 4% A(1–42)633 detected by ThT and Atto633 fluorescence. G, Pearson correlation analysis of100 aggregates from three indepen-
dent samples indicates that ThT and Atto633 fluorescence are highly correlated in labeled A fibrils; all scale bars, 1 m; *** indicates p 0.001.
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A(1–42) was observed at concentrations of 150 nM and
below (Fig. 4, C and D). In contrast, no such threshold con-
centration existed for the internalization of preformed
A(1–42)565 aggregates (Fig. 4, E and F). The observed
threshold concentration for monomer uptake is similar to
the critical concentration (22) that was reported for the
FIGURE2. InternalizationofA(1–42)dependsonaggregationstates.A–E,SH-EPcellswere incubatedwithpurifiedmonomersorprotofibrilsat37 °Cfor24h,and
imagedbyconfocalmicroscopy,A(1–42)565 fluorescence (red), calcein fluorescence (green).A,A(1–42)protofibrils (PF, 150nM);B,monomericA(1–42) (M, 500nM);
C,monomericA(1–42) (M, 150nM);D, sc-A(1–42)565 (sc, 500nM); and E,negative control (n.c.). Scale bars,10m. F, average fluorescence intensities per pixel inside
endocytic vesicles, in the cytosol and in the extracellular space were calculated from the 565 nm channel of confocal images in A–E. Bar graphs represent average
values  S.D. from image areas corresponding to endocytic vesicles marked by calcein (n  10), or from areas in the cytosol without vesicles (n  3) or in the
extracellular space (n  3), respectively. Only cells treated with aggregated A(1–42)565 (150 nM; PF, 150) or monomeric A(1–42)565 (500 nM; M.500) displayed
fluorescenceabove thebackgroundofuntreatedcells (n.c.),whereas those treatedwithA(1–42)565monomersat150nM (M.150) andsc-A(1–42)565 (500nM; sc.500)
did not. Inset, cells treated under conditions that resulted in uptake of A(1–42)565 aggregates displayed a 3-fold increase in cytosolic A(1–42)565 signal compared
with the extracellular space. A(1–42)565 fluorescence in the cytosol is 30-fold lower than inside the vesicles. G, Pearson correlation analysis of colocalization
between calcein andA(1–42)565 fluorescence in panels A–E. Bars indicate average R values of three regions of interest S.D., ***, indicates p 0.001; **, p 0.007.
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aggregation of A(1–42) monomers, which suggests that
aggregation may be a prerequisite for uptake.
Alternatively, differences in the degradation of A(1–42) by
proteases, either extracellular prior to uptake or intracellular,
could cause the higher amount of A(1–42) in the cells. To test
this alternative hypothesis, we monitored concentrations of
A(1–42) in the cell culture media and in cell lysates as a func-
tion of time by immunoblotting (Fig. 4,G andH). We observed
a pronounced increase of A(1–42) in the lysates of cells incu-
bated with aggregated A(1–42) (500 nM) and a smaller
increase in cells incubated with monomer (500 nM) after 24 h,
mirroring the results from HCS microscopy (Fig. 4B). We then
monitored the A(1–42) concentration in the culture media,
either in the presence of cells or in control samples that were
incubated without cells for 24 h. When monitoring the A(1–
42) concentration in the culture media, no decrease of A(1–
42) over time was observed for monomeric A(1–42) in the
presence of cells or for either form of A(1–42) in the control
samples without cells. These data indicate that monomeric
A(1–42) is not degraded by proteases in the media, which
would prevent its uptake. Rather, only the concentrations of
aggregated A(1–42) were reduced substantially over time,
likely reflecting its more efficient binding to, and uptake into
cells. Taken together, these data strongly support our initial
hypothesis that uptake of A(1–42) does indeed depend on its
aggregation state. If so, it would be important to determine the
type of aggregates that are efficiently taken up by the cells.
Efficient Uptake Correlates with Formation of -Sheet-rich
Aggregates—To determine which A species could be effi-
ciently taken up, we combined in vitro aggregation kinetics and
cellular uptake experiments. A(1–42) amyloid formation was
monitored in vitro to collect A(1–42) species at different
FIGURE 3. Internalization of A(1–42) by primary neurons and immunofluorescence staining of internalized A(1–42). A–C, primary hippocampal
neurons incubatedwith pre-aggregated A(1–42)565 at 150 nM (A), monomeric A(1–42)565 at 500 nM (B), ormonomeric A(1–42)565 at 150 nM concentration
(C). Nuclei were stained by Hoechst 33342 (blue), endocytic vesicles were stained with calcein (green). D–F, co-staining of the internalized A(1–42) with
anti--amyloid antibody. SH-EP cells were incubated with A(1–42)565 (500 nM, equivalent monomer concentration) (D and E), or Atto 565 dye (F) at 37 °C for
24 h. Fixed cells were co-stained by anti-A antibody (6E10) by IF staining, visualized by Cy5-conjugated secondary antibody (cyan), and imaged by confocal
microscopy. Cell nuclei were stained with Hoechst 33342 (blue). D, internalized A(1–42)565 was co-stained by 6E10/Cy5. E, no secondary antibody bound
without primary antibody (6E10) to A(1–42)565. F, Atto565 dye was not taken up, and 6E10/Cy5 did not mark dye molecules; scale bars, 10 m.
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FIGURE 4. Internalization of A(1–42) depends on concentration. A, HCS microscopic images of SH-EP cells with A(1–42)565 aggregates. Left, cell
nuclei were stained with Hoechst 33342 (white). Nuclei, which locate in focus plane, were identified by the image analysis software (blue contour lines).
Right, the software identification of nuclei (blue contour lines) in the cell bodies (red contour lines) and A(1–42)565 aggregates inside the cell bodies
(yellow spots); scale bars, 100 m. B, SH-EP cells were incubated with purified A(1–42)565 monomer (200 nM) at 37 °C from 1 to 49 h. Intracellular
A(1–42)565 in fixed cells was analyzed by HCSmicroscopy. Maximal intracellular A(1–42) was reached after 27 h. C–F, SH-EP cells were incubated with
A(1–42)565 monomer (C and D) or aggregates (E and F) at 37 °C for 24 h. Total fluorescence intensities A(1–42)565, cell number per well, the number
of A(1–42)565 aggregates per cell, and total aggregates area were plotted as functions of A(1–42)565 concentration. All results are represented as
mean  S.D. of 6 replicate wells. G and H, quantification of A(1–42) of SH-EP cells incubated with A(1–42) monomer (500 nM) or aggregates in cell
lysates (G) and cell culture media by dot blotting (H, mAb 6E10). Differences between 0, 1-, 3-, and 24-h incubation samples incubated under the same
conditions were not statistically significant. Bars representmean S.D. of three replicate wells; *** indicates p 0.001; ** indicates p 0.003; * indicates
p  0.05.
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stages of aggregation. Then their uptake was monitored
through the fluorescence of labeled A(1–42).
A(1–42) (15 M, 10% A(1–42)565) aggregation kinetics
were monitored by ThT fluorescence (Fig. 5A). Samples were
collected at four time points that corresponded to different
phases of peptide aggregation: initiation (t0), lag-phase (t1),
growth phase (t2), and plateau phase (t3). The samples were
characterized by CD spectroscopy (Fig. 5B). Within the lag
phase (t0 and t1), A(1–42) partially lost its disordered state. It
adopted a-sheet structure during the growth phase (t2 and t3)
as indicated by a minimum at 218 nm in the CD spectra. When
centrifuged at 200,000 g, solubleA(1–42)was lost during its
growth phase (t2–t3, Fig. 5C). To determine which of these
aggregation states are efficiently taken up, the SH-EP cells were
incubatedwithA species (t0–t3) at 37 °C at 150 nM equivalent
monomer concentration, which is below the threshold concen-
tration of A(1–42)565 monomer internalization (Fig. 4D).
After 24 h incubation, intracellular A(1–42) aggregates were
quantified by HCS microscopy (Fig. 5D). Intracellular A(1–
42)565 aggregates were detected in cells that had been treated
with growth (t2) and the steady-state phase (t3) aggregates. In
contrast, no uptake of A(1–42) peptides was observed with
samples from the initiation (t0) and lag phase (t1) of the poly-
merization reaction. This suggests that -sheet-rich A(1–42)
aggregates are efficiently internalized, whereas unstructured
monomers (t0) or small aggregates/oligomers (t1) without
-sheet structure are not.
HCSdata fromFig. 4,C andE, show that neither form,mono-
mer or small aggregates, had a strong effect on the number of
living cells, i.e. internalized A(1–42)565 did not cause cell
death within 24 h. We therefore analyzed cell metabolic activ-
ities by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) reduction, which is a well established marker
of early mitochondrial toxicity (23).
A(1–42) aggregates formed during the growth phase (t2
and t3) were significantly more toxic than monomers (t0) and
samples collected during the lag-phase (t1) and inhibited mito-
chondrial metabolic activity (Fig. 5E). Under our experimental
conditions A(1–42)monomers became cytotoxic only at con-
centrations above 150 nM (Fig. 5F), a point at which they also
underwent internalization (Fig. 4, C and D).
It should be noted that the dilution to 150 nM might change
the structure of A(1–42) in the medium from the structure
recorded by CD at 15 M (Fig. 5B). Nevertheless, at concentra-
tions of 150 nM and below only A(1–42) that had previously
formed -sheet-rich structures (t2, t3) was efficiently internal-
FIGURE 5.A(1–42) uptake of-sheet structures. A, aggregation kinetics of monomeric A(1–42) (15M) with 10%A(1–42)565 in PBSweremonitored by
ThT fluorescence. Aggregateswere collected from the aggregation assay at four timepoints (t0–t3). B,A(1–42) secondary structurewasmeasuredby circular
dichroism spectroscopy. C, quantification of soluble A(1–42) by SDS-PAGE and Coomassie staining after ultracentrifugation for 30min at 200,000 g.D, A
(t0–t3)wasdiluted to a final concentrationof 150nMadded to SH-EP cells for 24h incubation time. InternalizedA(1–42)565wasquantifiedbyHCSmicroscopy
of fixed cells. E,metabolic activities of SH-EP cells treated with A (150 nM, t0–t3) or untreated cells (n.c.). After 1 day of incubation, metabolic activities were
monitored by MTT assay. F,metabolic activities of SH-EP cells treated with monomeric A at 0–600 nM. After 1 day, the toxicity was monitored by MTT assay.
All results are represented asmean S.D. of three replicate wells for ThT kinetics (A), of 6 replicate wells for uptake (D) and 12 replicate wells for MTT assays (E
and F); *** indicates p 0.001, ** indicates p 0.003; n.s., not significant.
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ized, whereas unstructured monomers (t0) or small aggregates
(t1) without -sheet structure were not. This suggests that it
was indeed the -sheet aggregates that were taken up, rather
than a different A(1–42) species. The question whether the
intracellular A(1–42) still had -sheet structure will be
addressed in detail below.
These data support the hypothesis that the formation of a
-sheet structure may be a prerequisite for efficient uptake and
subsequent cytotoxicity of A(1–42) aggregates in neuronal
model cells. The results raise the question where A(1–42)
aggregates form. Aggregation could occur in the medium or,
alternatively, the cellularmembranemay serve as a platform for
the aggregation process.
Multimerization on Plasma Membrane Precedes Uptake of
A(1–42)—To investigate the location of aggregate formation
and to better track the dynamics of monomer uptake, we
repeated the uptake experiment under conditions that allowed
us to separate in timeA(1–42)membrane interaction from its
uptake into the cell. The cells were cooled to 4 °C, which slows
down both A(1–42) aggregation and cell metabolism, and
then were treated with A at 4 °C for 45 min. The cells were
then washed with ice-cold PBS to remove unbound A(1–42),
and then restored at 37 °C in fresh media (Fig. 6A).
Under these conditions (4 °C, 60min), even at ahighermono-
mer concentration of 1 M, A(1–42)565 was located only on
the plasma membrane and no uptake could be observed (Fig.
6B). Calcein (20 M) uptake displayed that the cell still had
some endocytic activity under these conditions.
First, we tested whether monomeric A(1–42) assembles
into larger species on the cell membrane.We incubated SH-EP
cells with two types of fluorescently labeled monomeric A(1–
42), A(1–42)488, and A(1–42)633. The self-assembly of
A(1–42) into di- and multimeric species was quantified by
FRET between both fluorophores. After preincubation at 4 °C
for 15 min, SH-EP cells were treated with monomeric A(1–
42)488 andA(1–42)633 (500 nM totalA(1–42) concentration)
at 4 °C for 45 min. Confocal imaging showed that both A(1–
42)488 and A(1–42)633 accumulated at the plasma membrane
(Fig. 6C). A(1–42)488 and A(1–42)633 not only colocalized
but also displayed a FRET signal, indicating direct interaction
between the two-labeledA(1–42) species. These data demon-
strate that at least a fraction of the monomeric A(1–42) pep-
tides rapidly co-aggregated on the plasma membrane.
We then tested if those membrane-bound A(1–42) aggre-
gates did indeed form on the plasma membrane and could be
taken up after their aggregation. To do so, SH-EP cells were
treated successively with monomeric A(1–42)488 and A(1–
42)633, each at 500nMconcentration. SH-EP cellswere first only
incubated with monomeric A(1–42)488 at 4 °C for 30 min,
whichwas thenwashedoff. After removing the unboundA(1–
42)488, the cells were treated with A(1–42)633 at 4 °C for
another 30 min. After that, the cells were washed again to
remove unbound A(1–42), incubated in fresh medium at
37 °C for 3 h to permit internalization of A(1–42), and imaged
by confocal microscopy (Fig. 6D). Both labeled A(1–42) spe-
cies colocalized in the endocytic vesicles. The FRET signal indi-
cates that both had formed di- or multimeric complexes.
Because the washing step had removed all A(1–42)488 from
solution, we conclude that A(1–42)488 interacted with A(1–
42)633 while located on the plasmamembrane. Themembrane-
bound aggregates were then taken up by endocytosis after the
cells were returned to 37 °C.
To verify that the FRET signal is specific to physical interac-
tion ofA(1–42)monomers and is not an artifact of the label or
of colocalization, we used transferrin (Tf) as a negative control.
Tf binds to a membrane receptor and is internalized via clath-
rin-mediated endocytosis but does not aggregate on the mem-
brane. After incubating the cells at 4 °C with two types of fluo-
rescent transferrin conjugates (Tf/A488 and Tf/A647), we
observed colocalization of both Tf conjugates. However, the
colocalization did not correspond to a FRET signal (Fig. 6E).
This strongly suggests that the FRET between A(1–42) mol-
ecules results from a specific physical interaction.
For a more comprehensive analysis of the membrane-as-
sisted self-assembly and subsequentuptakeofA(1–42)mono-
mers, the cells were treated with monomeric A(1–42)565 at
various concentrations (0–1600 nM) at 4 °C for 45 min. Subse-
quently the temperature was raised to 37 °C to permit internal-
ization of A(1–42) and the cells were incubated in fresh
medium for 24 h. Intracellular A(1–42)565 was then quanti-
fied by HCS microscopy (Fig. 6F). Intracellular A(1–42)565
aggregate signals could be detected at A(1–42)565 monomer
concentrations above 200 nM, similar to the threshold concen-
tration we previously observed for monomer uptake at 37 °C
(Fig. 4, B and C). These data demonstrate that A(1–42) binds
to the plasmamembrane and forms aggregates prior to cellular
uptake, that the cell membrane assisted A(1–42) self-assem-
bly, and that uptake of monomeric A(1–42) requires
a critical A(1–42) concentration for membrane-assisted
uptake.
Conceivably, small A(1–42) aggregates that are competent
for uptake could be forming in solution and then bind to the
plasma membrane. However, a comparison of conditions and
time scales of A(1–42) aggregation in solution with those of
the membrane binding experiment makes this hypothesis less
likely. Incubation of cells with A(1–42) monomer for 45 min
at 500 nM was sufficient to initiate uptake. In contrast, ThT
positive A(1–42) species did not form in solution under the
same conditions within 3 h even atmonomer concentrations of
1500 nM (Fig. 6G).
Finally, we probed the complex formation of A(1–42)488
and A(1–42)633 (150 nM each) by FRET as a function of time
(Fig. 6H). Little FRET signal was observed within the first 3 h,
supporting our conclusion that membrane binding coincides
with, or precedes interaction at this peptide concentration.
Conversely, no FRET signal was observed after the co-incuba-
tion of scrambled sc-A(1–42)488 and A(1–42)633 (150 nM
each), reinforcing that interaction depends on the A peptide
sequence and not on the fluorescent label. Formation of FRET-
positive species also coincided with the time course of A
aggregation in vitro (Fig. 6,G andH), suggesting that the FRET
signal results from multimeric aggregated A species.
We therefore conclude that binding to the plasmamembrane
occurredwithin the lag-phase of ThT aggregation kinetics, well
before the formation of -sheet-rich aggregates. Because our
previous experiment demonstrated that formation of -sheet
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structures in vitro correlated with efficient uptake (Fig. 5, B and
C), these data suggest that A(1–42) peptidesmay convert into
-sheet aggregates on the membrane prior to uptake after
soluble A(1–42)565 peptides were removed. We therefore
analyzed, whether intracellular A(1–42) contained -sheet
structures.
Internalized A(1–42) Contains -Sheet-rich Structures—
To identify the secondary structure of internalizedA(1–42) in
the cultured cells, we stained cells with the amyloidophilic dye
ThS and the anti-amyloid fibril antibody LOC after A(1–42)
uptake. ThS is widely used to visualize -sheet-rich amyloid
structures in histology (20, 24). It displays enhanced fluores-
cence emission on -sheet binding, and has higher affinity and
less pH sensitivity than ThT (20). When pre-aggregated A(1–
42) (t1–t3) is taken up, both ThS and LOC staining colocalize
with A(1–42)633 fluorescence confirming the presence of
fibrillar aggregates (Fig. 7, A and B). However, ThS and LOC
signals after incubation with monomeric A(1–42) do not
clearly demonstrate the presence of –sheet rich fibrils (Fig. 7,
A and B). This leaves open the possibility that the A(1–42)
species detected by FRET have not yet formed -sheet
structures.
Our previous experiments found: (i)monomericA(1–42) is
internalized at concentrations above 200 nM; (ii) A(1–42)
aggregates on the plasma membrane; and (iii) aggregates con-
taining -sheet structure were taken up very efficiently, all sug-
gesting a conversion of monomeric A(1–42) into -sheet
structure during uptake.
To resolve whether this conversion occurs, we performed a
competitive uptake experiment between monomer at a sub-
critical concentration (A(1–42)565, 150 nM), which was co-in-
cubated with -sheet aggregates (A(1–42)633, 900 nM). Both
species were labeled with different fluorophores to track in
which compartment both monomers and aggregates were
found. In addition,-sheet-rich structureswere stained byThS.
According to our previous results, we would expect monomers
to be taken up only if they converted into -sheet-rich struc-
tures via co-aggregation with pre-formed aggregates and that
internalized A(1–42) co-stains with ThS.
SH-EP cells were treated with A(1–42)565 monomer (150
nM) at 4 °C for 20 min. Monomeric A was removed, and then
cells were treated with A(1–42)633 aggregates at 900 nM at
4 °C for 20 min, washed with ice-cold cell culture medium, and
stained with ThS at 4 °C for 10 min. After that, the cells were
further incubated in fresh cell culture medium with calcein (20
M) at 37 °C for 1 h. After removing the calcein-rich medium,
the cells were incubated in calcein-free medium at 37 °C, and
live cell images were taken by spinning disk confocal micros-
copy (Fig. 7C).
A(1–42)565 was observed in both states, ThS positive (Fig.
7C, circle 1) and ThS negative (Fig. 7C, circles 2 and 3). In Fig.
7C, circles 1 and 2 show two structures that contained both
A(1–42)565 andA(1–42)633. However, only the ThS positive
structure colocalized with calcein (Fig. 7C, circle 1). In contrast,
ThS negative structures did not colocalize with calcein and
were thus not inside the endocytic vesicles (Fig. 7C, circle 2).
We quantified ThS fluorescence of A(1–42)565 monomers
that colocalizedwithA(1–42)633 fibrils andwithA(1–42)565
structures that did not contain A(1–42)633 (Fig. 7D). Only
A(1–42)565 that had coaggregated with A(1–42)633 fibrils
(Fig. 7D, F(fibril)/F(mono)5) stained strongly with ThS (p
0.008). In contrast, A(1–42)565 that had not coaggregated
withA(1–42)633 fibrils (Fig. 7D, F(fibril)/F(mono) 5) did not
colocalize with ThS. A structures that did not colocalize with
ThS were not internalized (Fig. 7C, circle 3).
We quantitatively analyzed internalized and surface-bound
species of monomeric A from confocal live cell imaging (Fig.
7E). All monomeric A found inside the cell both colocalized
with preaggregated A fibrils and stained strongly with ThS,
whereas1⁄3 of surface-bound monomeric A did not colocal-
ize with fibrillar A or stained with ThS. We did not find any
monomeric A that stainedwithThSwithout colocalizingwith
fibrillar A either inside the cells or on the cell surface under
these experimental conditions.
This means that subthreshold concentrations of A(1–42)
monomers were capable of binding to the plasma membrane.
However, co-aggregation into -sheet-rich structures was
needed for their efficient uptake into the cells.
Finally, we monitored the incorporation of A monomers
into -sheet-rich aggregates on the surface of SH-EP cells by
live cell FRET imaging (Fig. 7F, supplemental Fig. S1). Mono-
mericA coaggregatedwithA fibrilswithin 30min into struc-
tures that also bound ThS. Taken together, these data strongly
support our hypothesis, that aggregation into -sheet struc-
tures facilitates the efficient uptake of A(1–42) by neuroblas-
toma cells via an endocytic mechanism.
A(1–42) Aggregate Uptake Is Clathrin Independent—The
location of A(1–42) aggregates in endocytic vesicles raises the
question by which endocytic pathway -sheet-rich aggregates
are internalized. Here we tested whether A(1–42) aggregates
are internalized by clathrin-mediated endocytosis (CME). The
CME pathway was blocked by lowering the temperature to 4 °C
FIGURE 6. Aggregation of A(1–42) occurs on the plasmamembrane. A, experimental scheme. SH-EP cells were incubated with monomeric A(1–42) at
4 °C, then cells were either imaged directly or A(1–42) was washed off, the cells were further incubated in fresh medium at 37 °C. Intracellular A(1–42) was
quantified by confocal microscopy or HCS microscopy. At 4 °C, A(1–42) monomers bound only to the plasma membrane, and at 37 °C endocytosis of
A(1–42) aggregates occurred. B, after incubatingwithmonomeric A(1–42)565 (1M) and calcein (20mM) at 4 °C for 60min, A(1–42)was located only at the
plasmamembrane of SH-EP cells, no uptake could be observed. C, SH-EP cells were incubatedwithmonomeric A(1–42) (500 nM total A(1–42)) at 4 °C for 45
min. A(1–42)488 toA(1–42)633 FRET indicated aggregates species bound to theplasmamembrane.D, SH-EP cellswere treated successivelywithmonomeric
A(1–42)488 and A(1–42)633 (each 500 nM in themedium) at 4 °C for 30min, then incubated in freshmedium at 37 °C for 3 h. Colocalization and A(1–42)488
toA(1–42)633 FRET indicates that internalizedA(1–42)was in anaggregated form. E,SH-EPcellswere incubatedwith transferrin/Alexa488 (Tf/A488, 5 ng/ml)
and transferrin/Alexa647 (Tf/A647, 10ng/ml) at 4 °C for 45min.NoFREToccurredbetweencolocalized transferrin conjugates. Cells aremarkedbywhite outlines
in FRET panels. F, SH-EP cells treated with monomeric A(1–42)565 (0–1600 nM at 4 °C for 45 min) were then incubated in fresh medium at 37 °C for 24 h.
Intracellular A(1–42) was quantified by HCSmicroscopy; *** indicates p 0.001.G, normalized concentration-dependent A(1–42) (0.7–25M) aggregation
kineticsmonitored by ThT fluorescence in vitro. ThT positive-sheet structureswere formed after3 h at 700 nM. Scale bars, 10m.All results are represented
as mean S.D. of 6 replicate wells for uptake (a) and of three replicate wells for ThT kinetics. H, FRET signal Iacceptor (645 nm)/Idonor (530 nm) of A(1–42)
488 to
A(1–42)633 FRET pair (150 nM each) or sc-A(1–42)488/A(1–42)633 mixtures (150 nM each) incubated in PBS after excitation at 488 nm.
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(25). Transferrin binds to the transferrin receptor on the
plasmamembrane and then can be internalized via coated pits.
Fluorescent transferrin conjugates are therefore broadly used
asmarkers for investigating the early phase of CME (25–28). At
4 °C, transferrin only binds to its receptor on the plasma mem-
brane, and will not be taken up (25). Therefore, transferrin was
used as specifically reported for inhibition of theCMEpathway.
However, it should be noted that at this temperature the fluidity
of membrane is limited, which may also influence other endo-
cytic mechanisms or the aggregation of A(1–42) (29, 30).
Following incubation with monomeric and pre-aggregated
A(1–42)565 (150 nM, respectively) calcein (20 M) and trans-
ferrin (10 ng/ml) at 4 °C for 45 min, SH-EP cells were fixed and
imaged by confocal microscopy (Fig. 8, A and B). Transferrin
was located exclusively at the cell membrane, demonstrating
that CME was efficiently inhibited. Under these conditions
FIGURE 7. Internalized A(1–42) contains -sheet-rich structures. A, anti-amyloid fibril antibody (LOC) and thioflavin S (ThS) staining of internalized
A(1–42). SH-EP cellswere incubatedwith aggregation timepoints (t0–t3; see Fig. 5A) of A(1–42) (300nM) for 3 h, afterwhichA(1–42)was removedand the
cells were washed and cultivated overnight, fixed, and stained. Internalized A(1–42) was stained with LOC (i–iv, green) or ThS (v–vii, green). The cell cytoskel-
etonwas stainedwith phalloidin-568 (red) in panels i–iv. B, fluorescence of internalizedA(1–42)633 (t3, 150 nM) incubated for 6 h colocalizedwith ThS and LOC
signals; scale bar, 10 m for all panels. C, live cell imaging of internalized A(1–42). SH-EP cells were treated with A(1–42)565 monomer (150 nM) and
A(1–42)633 aggregates (t3, 900 nM), at 4 °C for 20min each and stainedwith ThS. After removing unboundA(1–42), the cellswere incubatedwith calcein (20
M) at 37 °C for 1 h. The live cell imagewas recorded by spinning disk confocalmicroscopy. Internalized aggregates that contained-sheet structures showed
positive ThS staining and positive calcein signals (circle 1). ThS negative A(1–42)565, colocalized with A(1–42)633 (circle 2) or by itself (circle 3), was not taken
up into endocytic vesicles and did not colocalize with calcein; scale bar, 10m. D, box plot of colocalization of monomeric A(1–42)565 with ThS in structures
that either did or did not contain fibrillar A(1–42)633. Only A(1–42)565 that had coaggregated with fibrillar A(1–42)633 stained with ThS; n 10, p 0.008.
E,degree of colocalizationof surface-bound and internalizedA(1–42)565monomerwithA(1–42)633 fibrils. F,NFRET analysis ofmonomeric A(1–42)555 (150
nM) and fibrillar A(1–42)633 (150 nM) coaggregation in SH-EP cells acquired by sensitized emission of live cell images by confocal microscopy.
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A(1–42) monomer was only observed on the plasma mem-
brane and was not internalized. However, the A(1–42) on the
membrane did not colocalize with transferrin. The uptake of
pre-aggregated A(1–42) species was reduced but not totally
inhibited under these conditions (Fig. 8A). However, A(1–42)
found in endocytic vesicles also did not colocalize with trans-
ferrin. These data suggest that uptake of A(1–42) is indepen-
dent of CME.
We then analyzed the internalization of A(1–42)565 aggre-
gates at 37 °C under conditions that permitted CME. Endocytic
markers were visualized by immunofluorescence staining (Fig.
9). No colocalization with clathrin (Fig. 9A) and LAMP2 (Fig.
9B) was observed, supporting that A(1–42) was not internal-
ized via CME. Rather, internalized A(1–42)565 colocalized
with caveolin (Fig. 9C) and EEA1 (Fig. 9D), confirming that
A(1–42)565 was localized in endocytic vesicles andwere taken
up in a CME-independent pathway.
Discussion
Taken together, our data allow us to map the first steps in
A(1–42) internalization starting from the monomeric pep-
tide. First, A(1–42) monomers or very early disordered olig-
omers bind rapidly to the plasma membrane. Their binding
partner could be either the lipid bilayer itself or plasma mem-
brane proteins. Numerous studies have demonstrated interac-
tion ofAwith lipid bilayers. Its role inA(1–42) uptakewill be
scrutinized in a future study. There, they aggregate either on
the membrane surface itself or in a compartment that is very
close to the membrane, from which they are taken up into
endocytic vesicles. The highly efficient uptake of -sheet-rich
structures suggests that aggregation into, or co-aggregation
with -sheet aggregates occurs.
For A(1–42) monomers, the peptide concentration has to
be sufficient to initiate the first two steps of the process, result-
ing in a threshold for internalization at the saturation concen-
tration, or critical concentration, for A(1–42) aggregation
(22). In contrast, no concentration threshold exists for the
internalization of preformed A(1–42) aggregates with
-sheet structure.
This has several implications for the possible mechanism of
A(1–42) toxicity. In our experiments metabolic inhibition
was directly correlated with the formation and uptake of
-sheet-rich aggregates. Aggregated species have been found to
play a central role in A(1–42) toxicity, not all of which are
large -sheet-rich structures (5). Although -sheet-rich A
that was efficiently endocytosed and that inhibited mitochon-
drial activity could be pelleted at 200,000 g (Fig. 5), very large
FIGURE 8. SH-EP cells were incubatedwithmonomeric (A) or pre-aggregated (B) A(1–42)565 (150 nM, red), calcein (20M, green), and transferrin (10
ng/ml, blue) for 45 min at 4 °C, and were imaged by confocal microscopy. Transferrin and A(1–42) monomer was observed in the plasma membrane.
A(1–42) aggregates could be detected inside the cells. Scale bars, 10 m.
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aggregate structures were unable to enter the cell. Our data
therefore suggest that neurons preferably take up -sheet-rich
oligomeric and protofibrillar structures of intermediate size. It
is tempting to speculate that small oligomersmay have a higher
affinity to the plasma membrane than the monomeric peptide,
facilitating the conversion to -sheet-rich structures and sub-
sequent internalization. Our results demonstrate that, unlike
monomers, preexisting A aggregates are internalized at low
nanomolar concentrations, which corresponds to previously
observed binding of A oligomers to neuronal plasma mem-
branes at nanomolar concentration (31, 32).
Our experiments did not provide evidence that uptake of
aggregates proceeds via CME. A(1–42) can enter the cells via
a non-clathrin-mediated pathway, and then locate in the endo-
cytic vesicles. Costaining with caveolin suggests a possible
uptake route via the caveolin endocytosis pathway. A(1–42) is
also believed to be involved in cholesterol and caveolin traffick-
ing (33).
A(1–42) aggregates may be taken up via receptor indepen-
dent endocytosis, as had been observed previously (34). Other
pathways for the internalization of amyloidogenic proteins
have beendiscussed. Synthetic peptide aggregates of sizes500
nm were taken up into HEK cells by nonspecific endocytosis,
whereas larger aggregates were internalized by a mechanism
similar to phagocytosis (35). Tau aggregates can be internalized
via micropinocytosis, mediated by glycosaminoglycans (36). It
is possible that A(1–42) aggregates enter the cell by the same
pathway.
Second, we found that A(1–42) aggregates can form in a
concentration-dependent manner through self-assembly of
A(1–42) on the plasma membrane and that internalized
A(1–42) aggregates have -sheet structure. It has long been
known that lipid interaction promotes A(1–40) transition to
-sheet structure (37) and our data support the interpretation
that this process is central to A uptake and toxicity. Our data
suggest the binding of A(1–42) to the lipid bilayer or tomem-
brane proteins may be the first step in the formation of cyto-
toxic A(1–42) aggregates de novo. Factors that increase parti-
tioning of A to the plasma membrane will therefore likely
promote the formation of-sheet-rich aggregates on themem-
brane. These include lipid peroxidation products, such as seco-
cholesterol and 4-hydroxy-nonenal that facilitate A mem-
brane binding and aggregation (38–40), divalent metal ions
promotingAmembrane interaction (41), and interactionwith
membrane proteins (16). Our data support a central role of
endocytosis inA cytotoxicity (15) andprovide strong evidence
that aggregation precedes endocytosis, a question that had pre-
viously not been conclusively resolved (7, 8). This experimental
evidencemay improve our understanding of AD pathology and
FIGURE 9. Co-staining of internalized A(1–42) withmarkers of endocytosis. SH-EP cells were treated with A(1–42)565 aggregates (150 nM, red) at 37 °C
for 24 h. Colocalization of internalized A(1–42)565 detected by clathrin (A), LAMP2 (B), caveolin (C), and EEA1 (D) by IF. The primary antibodies of endocytic
marker proteins were visualized by Cy5-conjugated secondary antibody (green), and were imaged by confocal microscopy. Nuclei were stained with Hoechst
33342 (blue). Part of internalizedA(1–42)565was colocalizedwith caveolin andEEA1; but notwith clathrin andLAMP2. Cell outlines aremarkedbydashed lines
derived from images with increased exposure times (not shown); scale bars, 10 m.
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may inform more focused therapeutic approaches targeting
membrane binding and self-assembly of the A peptide.
Experimental Procedures
Preparation of Monomers and Fluorescent Labeling of
A(1–42)—Synthetic human A(1–42) and A(1–42) with a
single N-terminal cysteine residue (Institute for Medical
Immunology, Charite´, Berlin, Germany) were dissolved in
hexafluoro-2-propanol and incubated at room temperature
overnight. After flash freezing by liquid nitrogen, hexafluoro-2-
propanol was removed by lyophilization (Savant SpeedVac,
Thermo), and the peptides were stored at20 °C until use.
To prepare unlabeled monomer, lyophilized A(1–42) was
dissolved in 10 mM NaOH, sonicated for 30 min in ice-cold
water bath, and passed through a 0.22-m and a 30-kDa filter
(Millipore). Themonomers were kept on ice and used immedi-
ately or within 1 h.
A(1–42) with a single N-terminal cysteine residue was
labeled by Atto488-maleimide (A(1–42)488), Atto565-ma-
leimide (A(1–42)565), or Atto 633-maleimide (A(1–42)633,
Atto Tec) at a 1:1.5 M ratio in NaOH (10 mM) containing 0.05
mM Tris(2-carboxyethyl)phosphine, pH 7.5, and at 4 °C over-
night. A(1–42)565 and free Atto565-maleimide were sepa-
rated by SEC (Superdex 75, 3.2/20 column,GEHealthcare)with
a flow rate at 40 l/min in 10 mM NaOH.
Scrambled-A(1–42) (Millipore, sc-A(1–42)) was dis-
solved in 10 mM NaOH and labeled with Atto565-NHS (sc-
A(1–42)565). The labeling process and the separation of
sc-A(1–42)565 and free dyes were the same as described
above. A(1–42) labeled at the N terminus with Hylite555
(A(1–42)555, Anaspec) was monomerized as described above
for unlabeled A(1–42).
Monitoring Aggregation Kinetics of A(1–42) by ThT and
SDS-PAGE—A(1–42)monomer aggregation assays were per-
formed in PBS or 50 mM sodium phosphate, pH 7.4, as indi-
cated, containing 20 M ThT in a microplate reader (InfinitE
M200, Tecan, Austria) at 37 °C. ThT fluorescence (excitation
wavelength of 440 nm and emission wavelength of 485 nm) was
measured every 5 min after 5 s shaking. 50 l of A(1–42) was
removed at different time points as indicated and centrifuged
for 30 min at 200,000  g (Beckman TL-100). Supernatants
were analyzed by denaturing SDS-PAGE.
Circular Dichroism Spectroscopy—A(1–42) samples (15
M) in PBS were measured in a 1-mm path length cuvette. Cir-
cular dichroism (CD) spectra were recorded between 200 and
260 nm with a step size of 1 nm in a CD spectrometer (J-720,
Jasco, Japan).
Atomic Force Microscopy—10-l samples were loaded onto
freshly cleaved mica (mica was glued on a glass slide) for 5 min,
washed with freshly filtered deionized water (3  100 l), and
dried overnight. All the images were taken using intermittent
contact mode on a Nanowizard II/Zeiss Axiovert setup (JPK).
Cell Culture and Cellular Uptake—SH-EP cells were main-
tained in culture medium (10% (v/v) fetal bovine serum, 4 mM
L-glutamine, 110 mg/liter of sodium pyruvate, 100 units/ml of
penicillin-streptomycin, 4.5 g/liters of D-glucose in 500 ml of
Dulbecco’s modified Eagle’s medium (Gibco)) at 37 °C and 5%
CO2. Cells were seeded into 96-well plates or 35-mm cell cul-
ture dishes (MatTek) and grown to about 80% confluence. For
cellular uptake, the cells were incubated with A(1–42) or
labeled A(1–42) at various concentrations, temperatures, and
times. The cells were then washed twice with PBS and fixed
with 3.7% paraformaldehyde for 10 min at room temperature.
Primary rat hippocampal neurons were a gift of J. Meier, MDC
Berlin, and prepared and cultured as previously described (42).
Dot Blot Quantification of A—SH-EP cells were cultured as
described above and seeded in a 96-well plate (10,000 cells/well)
for quantification of A(1–42) in supernatant and in a 12-well
plate (80,000 cells/well) for quantification of A(1–42) in cell
lysate. Cells were incubated with monomeric A(1–42) or
A(1–42) that was pre-aggregated to the t3 time point (Fig. 5A)
in sodium phosphate buffer (50 mM, pH 7.4) as indicated. Cells
were washed in PBS, lysed in 100 l of Tris buffer (50 mM, pH
5.1) containing 2% SDS, and boiled for 10 min. 100 l of cell
lysates or culturemedia was run through a nitrocellulosemem-
brane (Bio-Rad) on a 96-well vacuum apparatus. Serial dilu-
tions for monomeric and pre-aggregated A(1–42) were spot-
ted in triplicate on the samemembrane as the cell samples, and
were used as standard reference for calculation of A(1–42)
concentrations. The membrane was incubated with blocking
buffer (5% BSA in PBS) for 1 h, was washed twice with PBS-T
buffer (0.1% Tween 20 in PBS) for 10 min, and then incubated
for 1 hwith primary antibody, anti--amyloidmousemonoclo-
nal antibody (1:500, 6E10, Covance), followed by secondary
antibody, IRDyeGAM-800CW (1:15,000, Li-Cor), in PBS-T
buffer containing 0.5% BSA. Fluorescence of three replicate
wells was evaluated through densitometry. A concentrations
were calculated from signals of reference dilution samples by
linear regression analysis.
Thioflavin S Staining—Thioflavin S (ThS) was dissolved in
50% ethanol to 1 mg/ml, and stored at 4 °C. Fixed cells were
stained with 0.01% ThS for 5 min, washed 3 times with 70%
ethanol; incubated with 0.25% KMnO4 for 4 min, rinsed with
water; incubated with 1% NaHBO4 for 4 min; then incubated
with 3 PBS (411 mMNaCl, 8.1 mM KCl, 30 mMNa2HPO4, 5.2
mM KH2PO4, pH 7.2) at 4 °C for 30 min and rinsed with water.
For live cell imaging, cells were incubated with ThS at 10
g/ml in cell culturemedium at 37 °C for 10min. Then the cells
were washed five times with PBS and kept in cell culture
medium until microscopy.
ImmunofluorescenceStaining(IF)—Toexamineifthedyefluo-
rescence of A(1–42)565 accurately reports the formation of
intracellular A(1–42) aggregates and their cellular locations,
the cells were co-stained with anti--amyloid mouse monoclo-
nal antibody (6E10, Covance), polyclonal anti-amyloid fibril
antibody LOC (1:800, Millipore), phalloidin-568 (1:500,
Fisher), or endocytic markers by IF after treatment with A(1–
42)565 aggregates. The fixed cells were permeabilized with 0.5%
TritonX-100 at room temperature for 5min,washed twicewith
PBS. Then cells were incubatedwith blocking buffer (3%BSA in
PBS) at room temperature for 1 h, and were incubated with
primary and secondary antibody (diluted at 1:2000) in blocking
buffer in the dark at room temperature for 1 h, respectively. The
following primary antibodies for endocytic marker proteins
were used: anti-caveolin-1 (Santa Cruz), anti-clathrin heavy
chain (Abcam), anti-EEA1 (C45B10, Cell Signaling), and anti-
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LAMP2 (Abcam) antibodies. Cell nuclei were stained with
Hoechst 33342. The dishes were stored in the dark until being
viewed by confocal microscopy or epifluorescence microscopy
(Zeiss Axiovert, 63/1.4 NA oil immersion objective) as indi-
cated. Colocalizationwas analyzed by Pearson correlation anal-
ysis using the coloc2 plug-in of Fiji. Thresholded Pearson anal-
ysis was used for colocalization of A(1–42)565 with calcein
fluorescence to include only endocytic vesicles that contained
calcein.
High-content Screening andAnalysis—ForHCS experiments,
cells were seeded into 96-well plates. The fixed cells were
stainedwithHoechst 33342 to visualize the nuclei. Nine images
per well were recorded by a HCS microscope (Cellomics,
Thermo Scientific) with a10 objective. For the compartmen-
tal analysis, the ArrayScan VTI software was used to identify
nuclei by Hoechst 33342 fluorescence, to fit cell dimensions
and to identify A(1–42) aggregates through Atto 565 fluores-
cence (Fig. 4A).
MTT Assay—SH-EP cells were seeded into 96-well plates,
grown to about 80% confluence and treated with different
aggregates species of A(1–42) at various concentrations. Cells
were washed to remove extracellular A(1–42). Each experi-
ment was carried out in two separate 96-well plates. One plate
was prepared for determination of cell number byHCSmicros-
copy; a parallel plate was used for the MTT assay (Promega).
The cells were incubated at 37 °C for 4 h after adding MTT (15
l/well) and for 1 h after adding solubilization solution (100
l/well). The absorbance ofMTTwas recorded at 570 nmusing
a plate reader. Statistical analysis was performed by Student’s
t-test assuming two-tailed distributions with equal variances.
Confocal Microscopy and Fo¨rster Resonance Energy Transfer
(FRET) Image Analysis—All confocal microscopy experiments
were performed in 35-mm dishes. The images of fixed samples
were recorded with a confocal microscope (Sp5, Leica, Ger-
many, Leica HyD hybrid detector) with an 63/1.4 NA oil-
immersion objective at room temperature. Live cell images
were recorded by spinning disc confocal microscopy (Olympus
IX83 microscope with Yokogawa CSU-W1 Confocal Spinning
Disc unit, Japan, and Evolve 512 EMCCD Camera) with 60/
1.2 NA water immersion objective. Live cell FRET images were
recorded with a confocal microscope (Nikon A1Rsi, GaAsP
PMT detector) with a60/1.4 NA oil immersion objective. For
live cell images, the temperature of the incubation chamber on
the microscope was set to 37 °C, and 5% CO2 was filled into
the incubation chamber. The fluorescence was measured for
Hoechst 33342with excitationwavelength of 405 nm and emis-
sion wavelengths of 420–460 nm; Atto488 with excitation
wavelength of 488 nm and emission wavelengths of 500–600
nm;Atto565with excitationwavelengths of 543, 561, or 565 nm
and emission wavelengths of 550 or 580–610 nm; Atto633 and
Cy5with excitationwavelengths of 633 or 640 nm and emission
wavelengths of 650–800 nm; calcein with excitation wave-
length of 488 nm and emission wavelengths of 490–540 nm.
The images for sensitized emission FRET analysis were
recorded by confocal microscopy described as above. For
Atto488-Atto633 FRET pair, the fluorescence was measured
with excitation wavelengths of 488, 633, and 488 and emission
wavelengths of 500–600, 650–800, and 650–800 nm for
Atto488, Atto633, and A(1–42)488 to A(1–42)633 FRET,
respectively. Correspondingly, FRET between Hylite 555 and
Atto633 was calculated from confocal images recorded with
excitation at 561, 638, and 561 nm and emission at 570–600,
650–800, and 650–800 nm. Corrected FRET images were cal-
culated from FRET, donor, and acceptor pixel intensities using
the Fiji distribution and the PixFRET plug-in (43). The cor-
rected FRET intensity for each pixel is given by,
IFRET  IFRET
0  BTdonor  Idonor  BTacceptor  Iacceptor
(Eq. 1)
where IFRET is the raw fluorescence intensity of the FRET chan-
nel, Idonor and Iacceptor are the fluorescence intensities of the
donor (Atto488 or Hylite 555) and acceptor (Atto633), respec-
tively. IFRET is normalized (nFRET) as a function of the square
root of the product of donor and acceptor intensities.
nFRET 
IFRET
Idonor  Iacceptor
 100 (Eq. 2)
Intensity-independent donor and acceptor bleed-through
(BT) were determined by,
BTdonor 
IFRET
Idonor
(Eq. 3)
BTacceptor 
IFRET
Iacceptor
(Eq. 4)
which were fitted with a linear model.
In vitro FRETofA(1–42)488/A(1–42)633was calculated as
the ratio of Iacceptor (645 nm)/Idonor (530 nm) after excitation at
488 nm in a Spectramax i3x (Molecular Devices) fluorescence
plate reader.
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